Traditional medicine has been part of human healthcare for centuries, but in recent years it has begun gaining stronger global recognition through scientific validation and regulatory frameworks. A recent development at the WHO Global Traditional Medicine Summit held in New Delhi highlighted this shift when Narendra Modi and Tedros Adhanom Ghebreyesus unveiled a commemorative postage stamp honoring Ashwagandha.
This symbolic gesture represented more than recognition of a single herb—it underscored the growing global interest in evidence-based traditional medicine and the role that scientifically validated herbal remedies may play in modern healthcare systems.
Ashwagandha: From Ancient Herb to Global Interest
Ashwagandha (Withania somnifera) has been widely used in Ayurveda for thousands of years. Traditionally classified as a Rasayana herb in Ayurveda, it has been associated with promoting vitality, resilience to stress, and overall well-being.
In recent decades, Ashwagandha has attracted international scientific interest due to its adaptogenic properties and bioactive compounds known as withanolides. Researchers across the world are studying its potential effects on stress management, cognitive health, metabolic balance, and immune function.
The recognition at the summit signals how traditional knowledge, when supported by modern research, can achieve wider acceptance across global healthcare systems.
Key Discussions at the WHO Summit
A significant session at the summit was the expert panel titled “Ashwagandha: From Traditional Wisdom to Global Impact.” The discussion was organized by the WHO Global Traditional Medicine Centre in collaboration with India’s Ministry of AYUSH.
The panel brought together scientists, regulators, and industry leaders to address critical issues affecting the global herbal industry, particularly those related to product quality, adulteration, and regulatory standards.
The Challenge of Ashwagandha Adulteration
One of the most significant concerns raised during the panel discussion was the issue of adulteration in commercial Ashwagandha products.
Research findings presented during the summit indicated that nearly 60% of tested formulations contained phytochemicals associated with Ashwagandha leaves rather than the root, which is traditionally recognized as the primary medicinal part of the plant.
This discovery raised concerns among researchers and regulators because different parts of a plant can contain significantly different phytochemical profiles. In the case of Ashwagandha, leaves and roots contain varying concentrations of bioactive compounds, which may affect both the safety and therapeutic properties of the final formulation.
Experts emphasized that including leaves or other non-root plant materials in formulations can potentially alter the expected biological effects of the herb.
Traditional Knowledge and Modern Quality Standards
In classical Ayurvedic texts and traditional practice, Ashwagandha root has historically been used as the primary therapeutic component. Modern herbal research also focuses primarily on root extracts, particularly standardized extracts that contain defined levels of withanolides.
Because of this long-standing tradition and emerging scientific evidence, experts at the summit highlighted the need for root-only extraction practices to maintain product authenticity and therapeutic consistency.
Ensuring the correct plant part is used is essential for maintaining both quality and consumer trust in herbal medicine.
Government Advisory from the Ministry of AYUSH
India’s Ministry of AYUSH has previously issued guidance regarding the use of Ashwagandha leaves in Ayurvedic formulations.
The advisory highlighted several important points:
-
There is currently insufficient scientific evidence supporting the therapeutic efficacy of Ashwagandha leaves as a crude drug or extract.
-
Because of this lack of evidence, Ashwagandha leaves cannot currently be classified as an ASU (Ayurveda, Siddha, and Unani) medicine ingredient.
-
More extensive research is required to establish the safety and efficacy of Ashwagandha leaves for medicinal purposes.
Until such evidence becomes available, the advisory recommends avoiding the use of leaves in therapeutic ASU formulations.
Why Quality Standards Matter for the Global Herbal Industry
As Ashwagandha continues to gain popularity worldwide, maintaining strict quality standards becomes increasingly important.
The global herbal supplement market is expanding rapidly, but this growth also brings challenges related to authentic sourcing, standardization, and regulatory oversight. Without proper quality control, adulteration and inconsistent formulations can undermine both scientific research and consumer confidence.
Experts at the summit emphasized the importance of adopting:
-
Reliable botanical identification methods
-
Standardized extraction processes
-
Transparent sourcing practices
-
Strong regulatory compliance
These measures are essential for ensuring that traditional herbs like Ashwagandha maintain their integrity as they enter global markets.
Bridging Traditional Wisdom and Modern Science
The recognition of Ashwagandha at the WHO Global Traditional Medicine Summit reflects a broader shift in global healthcare thinking. Traditional medicine systems are increasingly being examined through the lens of modern science to validate their safety, efficacy, and quality.
When traditional knowledge is combined with rigorous scientific research and regulatory standards, it opens new opportunities for integrating natural medicines into modern healthcare.
Looking Ahead
Ashwagandha’s journey—from an ancient Ayurvedic herb to a globally researched botanical ingredient—illustrates the potential of traditional medicine when supported by evidence-based research.
However, this progress also highlights the need for responsible industry practices, strict quality standards, and continued scientific investigation.
As global interest in herbal medicine continues to grow, ensuring authenticity and maintaining the integrity of traditional remedies will be essential.
The message emerging from the WHO summit is clear:
The future of traditional medicine lies in combining ancient wisdom with modern scientific rigor.
